BMRN vs COMP · P/E 40, rev $2.85B vs rev $5.63B
Biomarin Pharmaceutical Inc (BMRN) versus Compass Inc (COMP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Compass Inc (COMP) is a real estate services company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. COMP currently screens at market cap $3.35B.
Not investment advice. Open the BMRN and COMP stock pages for the full models.
Not investment advice.